Abstract / Summary
This cross-sectional study assesses formulary coverage, patient cost-sharing, and prior authorization requirements for lower-emission inhalers among patients with asthma or chronic obstructive pulmonary disease across US commercial insurance plans.
Topics
Inhalation and Respiratory Drug DeliveryFormularyAsthmaAuthorizationPulmonary diseaseHealth insuranceCOPDOpen access